Skip to main content

EDITORIAL article

Front. Neurosci., 19 June 2023
Sec. Brain Imaging Methods
This article is part of the Research Topic Quantitative Susceptibility Mapping: Technical Advances and Clinical Applications View all 6 articles

Editorial: Quantitative susceptibility mapping: technical advances and clinical applications

  • 1School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
  • 2Department of Radiology, The Second Affiliated Hospital, Zhejiang University, Hangzhou, China
  • 3Department of Diagnostic Radiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong SAR, China
  • 4School of Information and Science and Technology, ShanghaiTech University, Shanghai, China

Quantitative susceptibility mapping (QSM) is a new magnetic resonance imaging (MRI) technique, which provides a non-invasive way to measure the spatial distribution of magnetic susceptibility (Liu et al., 2015a,b). QSM has been fueled by its unique ability to non-invasively quantify the spatial distribution of various biomolecules, an achievement that is promising to revolutionize our understanding of the brain's structure and function in health and disease (Li et al., 2023). This Research Topic, titled “Quantitative Susceptibility Mapping: Technical Advances and Clinical Applications,” shines a light on the rapid advances in this exciting field and the burgeoning array of clinical applications that these advances are making possible.

This Research Topic includes four original research papers and one review paper. A central theme that emerges from the papers in this Research Topic is the critical role that technical advances are playing in pushing the boundaries of QSM. Notably, the emergence of machine learning—and specifically deep-learning-based strategies—is propelling the field to new heights, offering the unprecedented potential for improved quantification accuracy and simplified preprocessing steps. He et al. proposed a novel k-QSM network to resolve dipole inversion issues in QSM reconstruction. The k-QSM network converts the results from truncated k-space division (TKD) into the Fourier domain as inputs. After passing through several convolutional and residual blocks, the ill-posed signals of TKD are corrected. Fuchs and Shmueli applied the incomplete spectrum approach to the field-to-source inverse problem encountered in quantitative magnetic susceptibility mapping (QSM). They showed that the incomplete spectrum QSM provides a new approach to handle the “ill-posed” regions in the frequency-space data input to QSM.

These sophisticated techniques may well prove pivotal in meeting some of the most significant challenges currently faced by QSM. However, the extraordinary potential of QSM extends far beyond these technical advances. Clinical applications of this technique are rapidly expanding, from tracking the progression of neurodegenerative diseases like Parkinson's disease and Alzheimer's disease (AD) to refining the implementation of deep brain stimulation surgery. Uchida et al. reviewed QSM as an imaging biomarker for Alzheimer's disease. They focused on the relationships among QSM, established biomarkers, and cognitive performance in AD. They also discussed the role of QSM as an imaging biomarker as well as the expectations and limitations of clinically useful diagnostic and therapeutic implications for AD. The application of susceptibility imaging has also been tested on 0.5T MRI by Qiu et al. to compare with the Susceptibility Weighted Imaging (SWI) at 0.5T and 1.5T. They found minor differences regarding the blood veins quantification. QSM has also been applied to investigate the brain using an ultrashort echo time sequence with a 3D cones trajectory (Jang et al.). They concluded that ultrashort echo time quantitative susceptibility mapping enables direct estimation of the magnetic susceptibility in the brain with a dramatically reduced total scan time with the use of a stretched 3D cones trajectory.

We hope that you will find the articles in this Research Topic both insightful and inspiring, and that they will spark new ideas and spur further research in this fascinating field. It is our privilege to present to you “Quantitative Susceptibility Mapping: Technical Advances and Clinical Applications”. The completion of this Research Topic involved the contribution of effort by authors and we want to take this opportunity to thank them all.

Author contributions

HW, PC, XG, and YZ wrote the manuscript. All authors contributed to the article and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Li, Z., Feng, R., Liu, Q., Feng, J., Lao, G., Zhang, M., et al. (2023). APART-QSM: An improved sub-voxel quantitative susceptibility mapping for susceptibility source separation using an iterative data fitting method. Neuroimage 274, 120148. doi: 10.1016/j.neuroimage.2023.120148

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, C., Li, W., Tong, K. A., Yeom, K. W., and Kuzminski, S. (2015a). Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J. Magn. Reson. Imaging 42, 23–41. doi: 10.1002/jmri.24768

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, C., Wei, H., Gong, N. J., Cronin, M., Dibb, R., and Decker, K. (2015b). Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications. Tomography 1, 3–17. doi: 10.18383/j.tom.2015.00136

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: quantitative susceptibility mapping (QSM), MRI, brain, SWI, clinical applications

Citation: Wei H, Guan X, Cao P and Zhang Y (2023) Editorial: Quantitative susceptibility mapping: technical advances and clinical applications. Front. Neurosci. 17:1228061. doi: 10.3389/fnins.2023.1228061

Received: 24 May 2023; Accepted: 05 June 2023;
Published: 19 June 2023.

Edited and reviewed by: Vince D. Calhoun, Georgia State University, United States

Copyright © 2023 Wei, Guan, Cao and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hongjiang Wei, aG9uZ2ppYW5nLndlaSYjeDAwMDQwO3NqdHUuZWR1LmNu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.